What the buyer wrote
NHS Framework Agreement for Adalimumab Injection Offer reference number: CM/PHR/19/5575 Period of Framework Agreement: 1 April 2020 - 31 March 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- NHS National Framework Agreement for Adalimumab Injection
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 31 Mar 2020
- Work ends
- 31 Mar 2022
- Kind of work
- Pharmacy and medicines
Who the buyer named
The buyer published a contact address on this notice.